In Focus

Some parents are wary of AI's ability to provide a holistic assessment compared to physicians. 

Some private equity investors have been diversifying to Southeast Asia, India, and Japan.

The country is heavily reliant on foreign players in CVD management.

The sector’s 2023 growth is expected to come from a low base effect from 2022.

Certain novel solutions could support the nuclear imaging equipment market in Japan.

This will help address issues on the quality of drugs in the market, Fitch Solutions said.

Some 19 COVID-19 drugs are in various phases of clinical development in the country.

The diagnostic imaging market is seen to grow at 5% between 2023 and 2030.

The country plans to roll out a healthcare platform to make healthcare accessible.

The market is expected to grow at a CAGR of 12.6% over the medium term.

There has been a growing interest towards researching cancer screening in the country.

Some local ministries banned public institutions from procuring imported medical equipment.

Only one in five is aware of the risk factors of stroke in the country.

Low government funding has affected the quality of healthcare in public hospitals.

The country's science agency opened a new national lab in Melbourne.

An elevated demand for prescription drugs has held back demand for OTC drugs.